On note, in studies comparing NPD and ICM as in vivo biomarkers of CFTR function, ICM was superior to NPD in distinguishing between patients with CF and healthy controls, and ICM demonstrated substantially greater power than NPD to detect low levels of residual CFTR function [50,80]. The gene discussed is CFTR; the disease is cystic fibrosis.